Direkt zum Inhalt
Merck

1148090

USP

Kollagenase II

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

Collagenase aus Clostridium histolyticum, Clostridiopeptidase A

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

CAS-Nummer:
EC-Nummer:
MDL-Nummer:
UNSPSC-Code:
41116107
NACRES:
NA.24

Qualität

pharmaceutical primary standard

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical

Format

neat

Lagertemp.

−70°C

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

Collagenase II is a metalloprotease that acts as an endoprotease and exhibits a tripeptidyl carboxypeptidase activity. It shows endopeptidic activity with the main cleavage site found in front of the human collagen duplex amino acids glycine-proline. Hydrolysis takes place in the interior of the triple helical domains of collagen. Collagenase II is also known as class II collagenase and consists of three subtypes: δ, ε, and ζ. Collagenase II USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung


  • Collagenase Type II for Enhanced Cell Isolation in Biomedical Research: Collagenase Type II is extensively applied in tissue dissociation for isolating cells, crucial for regenerative medicine and tissue engineering. It enables efficient breakdown of the extracellular matrix, facilitating easier cell extraction and purification for use in 3D cell culture and stem cell research. This enzymatic method is invaluable for studies requiring high-purity cell populations, making it indispensable in developing therapies for diseases like Parkinson′s and Alzheimer′s (Park et al., 2024).

  • Advancing Tissue Engineering with Collagenase II: In tissue engineering, Collagenase II plays a pivotal role by degrading the collagen matrix in tissues, thereby enabling the cultivation of cells in a controlled environment. This process is essential for constructing tissue structures from the ground up, particularly in developing organoids that mimic natural organ functionalities. The use of high-grade biotech collagenase ensures reproducibility and effectiveness in these sophisticated applications (Wu et al., 2024).

  • Collagenase II in 3D Cell Culture Systems: Collagenase II is instrumental in preparing extracellular matrices for 3D cell cultures, which are critical for studying cell behaviors in environments that closely replicate in vivo conditions. This enzyme helps in the accurate study of cellular interactions and pharmacological responses, providing a more realistic assessment of cellular dynamics in medical research (Jiang et al., 2024).

  • Role of Collagenase II in Stem Cell Research: Utilizing Collagenase II in stem cell research enhances the isolation and maintenance of stem cells. This is particularly important for applications where the integrity and viability of stem cells are crucial, such as in regenerative medicine and therapeutic cloning. The enzyme′s ability to gently dissociate cells while preserving their functionality makes it a staple in cutting-edge biomedical research (Simón-Pérez et al., 2024).

  • Collagenase II for Effective Extracellular Matrix Degradation: The ability of Collagenase II to efficiently degrade collagen-rich extracellular matrices is utilized in various biomedical applications, including cancer research where it aids in tumor microenvironment studies and drug penetration analyses. This enzymatic activity is crucial for understanding the interactions between cancer cells and their surrounding stroma, providing insights into potential therapeutic targets (Mohamed et al., 2024).

Biochem./physiol. Wirkung

Collagenase wird durch vier Grammatom Calcium pro Mol Enzym aktiviert. Sie wird durch Ethylenglycol-bis-(beta-aminoethylether)-N, N, N′,N′-tetraessigsäure, β-Mercaptoethanol, Glutathion, Thioglycolsäure und 8-Hydroxychinolin gehemmt.

Einheitendefinition

Eine Collagen-Aufschlusseinheit (Collagen Digestion Unit, CDU) setzt Peptide aus Rinder-Achillessehnencollagen entsprechend der Ninhydrin-Anfärbung von 1,0 μmol Leucin in 5 Stunden bei pH 7,4 und 37 °C in Gegenwart von Calciumionen frei. Eine FALGPA-Hydrolyseeinheit hydrolysiert 1,0 μmol Furylacryloyl-Leu-Gly-Pro-Ala pro Minute bei 25 °C. Eine neutrale Protease-Einheit hydrolysiert die Caseinmenge, die eine Färbung entsprechend 1,0 μmol Tyrosin pro 5 Stunden bei pH 7,5 und 37 °C produziert. Eine Clostripain-Einheit hydrolysiert 1,0 μmol BAEE pro Minute bei pH 7,6 und 25 °C in Gegenwart von DTT.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

This product is part of the USP Biologics program.

Piktogramme

Health hazard

Signalwort

Danger

H-Sätze

Gefahreneinstufungen

Resp. Sens. 1

Lagerklassenschlüssel

12 - Non Combustible Liquids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Yasin Emre Kaya et al.
Turkish neurosurgery, 30(3), 434-441 (2020-04-03)
To investigate the effects of metformin, a drug used widely for the treatment of type 2 diabetes mellitus, on human primary cell cultures prepared from uninjured segment of disc material intervertebral disk tissues. Primary cell cultures were prepared using the
Michalis Mastri et al.
American journal of clinical and experimental urology, 9(6), 416-434 (2022-01-08)
The evolving paradigm of the molecular classification of bladder cancer requires models that represent the classifications with less heterogeneity. Robust transcriptome based molecular classifications are essential to address tumor heterogeneity. Patient derived models (PDMs) are a powerful preclinical tool to

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.